TBRG TBRG R2KPHARMA

Q: What is the current share price of TBRG?

As of 2026-10-23 16:27 PDT, TBRG trades at $26.24 on NasdaqGM. Its 52-week range is $26.24 to $26.24.

Q: What is the market capitalisation of TBRG?

TBRG has a market capitalisation of $393.58M on NasdaqGM.

Q: What is the P/E ratio of TBRG?

TBRG trades at a trailing price-to-earnings (P/E) ratio of 90.48. The industry average P/E is 25.45. Its price-to-book (P/B) ratio is 2.16.

Q: What is the return on equity (ROE) of TBRG?

TBRG has a return on equity (ROE) of 2.54%. Its return on capital employed (ROCE) is 4.70%.

Q: Is TBRG a good stock to buy?

This page provides a data-driven analysis of TBRG, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Healthcare · Health Information Services · United States

https://trubridge.com

Company Profile ↓

$26.24

+0.00% 1Y

Mkt Cap$393.58M

P/E90.48

P/B2.16

52W High$26.24

52W Low$26.24

Book Value$12.14

EPS (TTM)$0.29

Company Overview

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in two segments, Financial Health and Patient Care. It offers revenue cycle management (RCM) products, including patient liability estimate, eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management services; RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services; consulting, business intelligence, staffing, and administrative services; cloud services, backup and recovery, collaboration and connectivity, security services, systems management, and help desk services; and encoder solutions. The company also provides TruBridge HER, a software solution platform which offers various software applications using one fully integrated system designed to streamline the flow of information to the primary functional areas of community hospitals. In addition, it offers acute care support and maintenance services comprising total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, instantPHR, and CHBase. Further, the company provides business management services; acute care EHR solutions and related services for community hospitals, and their physician clinics; and patient engagement and technology solutions. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama. As of July 9, 2026, TruBridge, Inc. operates as a subsidiary of Inventurus Knowledge Solutions Limited.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $346.84M (+1.4% YoY); net profit $4.35M.
Trailing 12 Months Year-on-year growth — revenue -1.1%, earnings +0.0%.
5-Year Trend Long-term compounding — revenue CAGR 2.0%, profit CAGR -35.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	2.02%
1 Year:	-1.10%

Compounded Profit Growth

5 Years:	-35.02%
1 Year:	0.00%

Stock Price Performance

1 Year:	+0.00%
6 Months:	-
3 Months:	-
1 Month:	-

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot

Price Performance

1Y+0.00%

Valuation vs Sector

P/E of 90.48 is above the sector median of 25.45 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Generates positive free cash flow.

CONS

Trading at a high P/E of 90.5.
Earnings shrank at -35.0% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

90.48

Industry PE

25.45

Forward P/E

8.86

PEG Ratio

0.32

Book Value

$12.14

Price to Book

2.16

P/S

1.14

EV/EBITDA

15.42

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

2.02%

Profit 5Y

-35.02%

Revenue (YoY)

-1.10%

Earnings (YoY)

0.00%

Profitability & Returns

ROCE

4.70%

ROE

2.54%

ROA

3.24%

Profit Margin

1.27%

Op Margin

4.70%

Gross Margin

53.22%

EPS (Latest Qtr)

$0.03

EPS (TTM)

$0.29

Balance Sheet & Liquidity

Debt/Equity

0.94

Quick Ratio

1.44

Current Ratio

1.78

Debt

$168.46M

Total Assets

$407.54M

Current Assets

$109.70M

Working Capital

$46.68M

Ownership

Promoter Holding

Chg in Prom Hold

FII / Inst Holding

Chg in FII Hold

Financial Snapshot

Enterprise Value

$393.58M

Total Revenue (TTM)

$345.90M

EBITDA

$33.82M

Free Cash Flow

$37.16M

Operating Cash Flow

$46.66M

Shares Outstanding

15.00M

Gross Margin

53.22%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	TBRG TBRG R2KPHARMA	26.24	90.48	$393.58M	0.00%	4.70%	2.54%	2.02%	-35.02%
2	LLY Eli Lilly and Company SPXR3KPHARMA	1,273.46	42.83	$1.14T	0.60%	-	102.29%	7.20%	11.41%
3	JNJ Johnson & Johnson SPXR3KPHARMA	263.81	30.60	$635.76B	1.98%	14.88%	25.74%	2.43%	4.76%
4	ABBV AbbVie Inc. SPXR3KPHARMA	285.64	80.69	$504.76B	2.54%	10.47%	-129.24%	1.75%	-29.06%
5	UNH UnitedHealth Group Incorporated SPXR3KPHARMA	418.09	26.85	$375.28B	2.47%	9.74%	14.15%	10.40%	5.43%
6	MRK Merck & Co., Inc. SPXR3KPHARMA	145.27	116.22	$358.41B	2.31%	-	6.96%	5.64%	10.01%
7	NVS Novartis AG PHARMA	151.12	22.83	$287.24B	3.36%	21.09%	30.35%	9.25%	26.22%
8	AZN AstraZeneca PLC NDXPHARMA	171.49	25.63	$265.96B	2.00%	15.97%	21.96%	9.82%	45.96%
9	TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA	673.82	36.30	$249.14B	0.29%	8.14%	13.51%	8.81%	12.95%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	64.08M	67.68M	67.11M	78.06M	70.88M	67.91M	69.30M	72.33M	69.14M	66.16M	68.70M	70.64M	69.76M	59.55M	68.33M	66.85M	68.00M	68.53M	70.09M	77.87M	82.73M	82.83M	86.23M	84.62M	82.71M	84.12M	85.60M	84.70M	87.21M	85.73M	86.11M	87.79M	86.27M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39.51M	41.27M	42.05M	40.14M	38.35M
Gross Profit	24.71M	22.73M	22.57M	36.09M	34.91M	32.77M	33.49M	32.70M	35.99M	34.38M	44.20M	39.09M	34.85M	36.11M	39.68M	37.12M	34.53M	35.91M	36.58M	36.11M	30.11M	35.42M	34.61M	34.85M	33.89M	35.29M	41.19M	40.67M	38.02M	42.06M	40.49M	-	-	-	-	47.70M	44.46M	44.06M	47.65M	47.92M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39.53M	40.83M	39.99M	42.67M	44.87M
Operating Income	8.39M	4.26M	4.61M	776.00K	5.26M	4.24M	4.09M	3.23M	4.45M	5.62M	-18.12M	7.65M	2.23M	5.36M	9.65M	6.05M	3.62M	6.01M	8.91M	6.13M	2.75M	6.20M	5.97M	4.91M	7.74M	4.53M	8.99M	4.59M	4.94M	6.29M	-1.91M	-5.21M	-588.00K	-2.15M	2.81M	8.16M	3.63M	4.07M	4.98M	3.06M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14.72M	10.37M	11.09M	6.29M	10.08M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.38M	3.06M	3.00M	2.87M	2.63M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.92M	698.00K	1.35M	-3.10M	582.00K
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.46M	-1.88M	-4.25M	1.19M	76.00K
Net Income	5.90M	3.54M	3.39M	-1.66M	2.00M	1.60M	2.00M	246.00K	1.59M	2.29M	-21.54M	3.97M	328.00K	5.75M	7.59M	3.44M	1.66M	4.13M	11.23M	4.09M	1.76M	5.27M	3.12M	4.14M	6.14M	2.74M	8.11M	3.08M	2.16M	3.08M	-2.84M	-3.56M	-1.85M	-4.39M	-9.15M	459.00K	2.58M	5.60M	-4.29M	506.00K
Diluted EPS	0.52	0.31	0.30	-0.13	0.15	0.12	0.15	0.02	0.11	0.17	-1.57	0.29	0.02	0.41	0.54	0.24	0.12	0.29	0.78	0.28	0.12	0.36	0.22	0.28	0.42	0.19	0.55	0.21	0.15	0.21	-0.20	-0.24	-0.13	-0.29	-0.61	0.03	0.17	0.37	-0.37	0.03
R&D Expense	3.57M	3.56M	-	7.19M	8.18M	8.40M	-	8.08M	8.41M	8.25M	-	8.76M	9.31M	9.30M	-	9.23M	9.30M	9.16M	-	8.27M	8.37M	8.55M	-	8.43M	6.47M	7.70M	8.06M	8.11M	7.99M	8.35M	8.77M	9.78M	10.69M	8.21M	7.74M	8.25M	8.11M	8.17M	-	7.45M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	127.74M	153.25M	173.48M	183.31M	200.86M	204.74M	182.17M	267.27M	276.93M	280.41M	274.63M	264.49M	-	326.65M	336.96M	342.20M	346.84M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	166.54M	175.56M	168.92M	162.97M
Gross Profit	53.26M	64.38M	79.41M	80.66M	93.74M	113.95M	94.46M	133.73M	147.27M	149.73M	144.15M	136.25M	-	160.11M	161.40M	173.28M	183.86M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	137.32M	168.83M	166.91M	163.03M
Operating Income	23.37M	29.10M	41.29M	41.28M	50.24M	49.59M	25.09M	14.38M	-4.81M	24.88M	24.58M	21.05M	-	22.78M	-7.43M	6.37M	20.83M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	47.73M	-18.62M	34.27M	42.46M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	6.32M	12.52M	16.17M	12.32M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	18.08M	-57.46M	-10.47M	3.87M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	2.21M	-9.33M	10.48M	-485.00K
Net Income	15.18M	18.74M	25.83M	29.97M	32.74M	32.92M	18.34M	3.93M	-17.42M	17.63M	20.47M	14.25M	-	15.87M	-48.13M	-20.95M	4.35M
Diluted EPS	1.39	1.71	2.34	2.71	2.95	2.94	1.62	0.29	-1.27	1.26	1.43	0.98	-	1.08	-3.15	-1.55	0.29
R&D Expense	-	2.33M	2.45M	2.76M	2.76M	14.62M	14.23M	29.09M	33.74M	36.37M	36.86M	33.46M	32.81M	31.90M	38.83M	35.45M	32.56M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	62.74M	75.64M	77.09M	92.53M	99.32M	92.79M	339.15M	318.22M	327.75M	339.59M	326.27M	-	430.96M	431.78M	395.82M	402.53M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	74.56M	108.81M	93.69M	104.64M
Cash & Equivalents	11.74M	4.39M	2.94M	6.66M	8.91M	11.73M	23.79M	24.95M	2.22M	520.00K	5.73M	7.36M	12.67M	-	6.95M	3.85M	12.32M	24.85M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	784.00K	475.00K	767.00K	623.00K
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	51.31M	56.24M	52.95M	54.97M
Total Liabilities	-	-	-	-	-	-	-	17.42M	181.18M	182.13M	167.96M	155.24M	126.27M	-	199.25M	247.80M	228.75M	224.57M
Current Liabilities	-	-	14.49M	16.67M	17.72M	21.45M	18.16M	17.42M	30.95M	40.85M	38.50M	41.93M	37.44M	-	44.45M	48.23M	56.00M	57.96M
Long Term Debt	-	-	-	-	-	-	-	0	146.99M	136.61M	124.58M	99.43M	73.36M	-	136.39M	195.27M	168.60M	161.24M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	147.24M	203.29M	174.81M	166.74M
Total Equity	40.56M	42.69M	46.46M	57.38M	57.20M	69.08M	80.78M	75.37M	157.97M	136.09M	159.78M	184.35M	200.00M	-	231.71M	183.97M	167.07M	177.96M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14.91M	15.12M	15.52M	15.68M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	8.81M	19.64M	33.54M	32.21M	29.05M	38.95M	30.88M	2.10M	23.64M	23.93M	43.60M	49.14M	-	32.38M	-522.00K	31.14M	36.97M
Investing Cash Flow	-2.16M	-5.31M	-14.03M	1.48M	-3.68M	-1.52M	-598.00K	-151.79M	-726.00K	-978.00K	-12.49M	-6.66M	-	-62.73M	-58.53M	5.12M	-14.72M
Financing Cash Flow	-14.01M	-15.78M	-15.79M	-31.44M	-22.55M	-25.36M	-29.12M	126.95M	-24.62M	-17.74M	-29.48M	-37.16M	-	25.88M	55.95M	-27.74M	-9.71M
Capital Expenditure	-829.10K	-5.09M	-10.85M	-4.36M	-3.63M	-1.47M	-448.00K	-39.00K	-726.00K	-978.00K	-1.76M	-3.34M	-	-19.37M	-21.82M	-18.11M	-17.13M
Free Cash Flow	7.98M	14.55M	22.69M	27.84M	25.42M	37.48M	30.43M	2.07M	22.92M	22.95M	41.84M	45.81M	-	13.01M	-22.35M	13.04M	19.84M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-4.48M	-3.10M	8.52M	12.53M
Share Buybacks	-	-	-	-	-	-	-	-	-	0	0	1.26M	1.31M	11.92M	2.58M	404.00K	1.95M
Dividends Paid	15.77M	15.79M	15.89M	31.44M	22.64M	25.53M	28.94M	25.09M	11.64M	5.62M	5.73M	4.34M	0	0	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	41.7%	42.0%	45.8%	44.0%	46.7%	55.7%	51.9%	50.0%	53.2%	53.4%	52.5%	51.5%	-	49.0%	47.9%	50.6%	53.0%
Operating Margin %	18.3%	19.0%	23.8%	22.5%	25.0%	24.2%	13.8%	5.4%	-1.7%	8.9%	9.0%	8.0%	-	7.0%	-2.2%	1.9%	6.0%
Net Margin %	11.9%	12.2%	14.9%	16.4%	16.3%	16.1%	10.1%	1.5%	-6.3%	6.3%	7.5%	5.4%	-	4.9%	-14.3%	-6.1%	1.3%
ROE %	35.6%	40.3%	45.0%	52.4%	47.4%	40.8%	24.3%	2.5%	-12.8%	11.0%	11.1%	7.1%	-	6.8%	-26.2%	-12.5%	2.4%
ROCE %	-	60.3%	70.0%	69.5%	70.7%	61.1%	33.3%	4.7%	-1.7%	8.6%	8.3%	7.3%	-	5.9%	-1.9%	1.9%	6.0%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for TBRG

Google News Fri, 22 May 2026

TBRG Posts Q1 Earnings: How to Play the Stock Amid Pending Sell-off? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQNWhEaW5odC1DbmJ3Rm9XQTY1SEZtTDFFVUVFZXBua1BOVXZIVkVVLV81c1czWjUxemZZSWdfdklrdjY4a25oR0lnZnR6X1RvYzRrTFdfeGY4dzZrQWFiRlcxNVhsZnJORmdscDYxVVFabmFacWNWWlU3SGpfSG9FVUduSE1JbjY3aVRxdE…

Google News Wed, 12 Aug 2026

TruBridge Inc. (NASDAQ: TBRG) Share Price, TBRG Stock News, TBRG Share Price & Updates - kalkine.ca

<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBhVTJ4M0ZRbmJVSjViOVhBS1ZmendhWXltOG5DWlFPb2t6VE12cDA1TGx6czNpSk5tVTE2ZlJ2ZGFiSUJUMkJfSEtGTUV1aHIw?oc=5" target="_blank">TruBridge Inc. (NASDAQ: TBRG) Share Price, TBRG Stock News,…

Google News Fri, 29 May 2026

TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQWVlKTkcybGk2Zl81dk5yamhBSFJLdmR5THZyckJQYlNuUFN4ODNXU1RFeUlHTkp2Z1N0VTdIYk5Mb2xuUHZaT3AwU1l1VEtMQjRIOGtVWTctc1k1LWl3WTQ4SDh0a2lqMVF2Zlg3NTRsNDhReXBLNzRCUDA1ZUhHUFE4TVBQbDlyNFlpZk…

Google News hu, 09 Jul 2026

TruBridge Announced Transfer or Voluntary Withdrawal of Listing - TradingView

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPd1p1QlFfaHUySEx4dnZ2OUxoejE5dXhLelYzampxbkRyQlJkS2lMTHZ2SV8tYzdIdWtHeGY3bndCTW41ZEVLdWRQVWtRcDRydGo2LWFCekhCdTllY29YSlBxZXVPVGJsX05NT2R6Y2NvYmJoNnJSNDd3eFVkR09CbU42eGxOZWlVNGtVM0…

Google News Sat, 11 Jul 2026

TruBridge Stockholders Approve IKS Merger at Special Meeting - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOb1FCRmdHZDFDbXhNcjM4dk1jbDludWttMTBncWRvampEOTg4NjRJN1BPZ2QwV2pqWlI4VVBLRHp0OERqYmF5SjJjSUNVOHZOLUxvbC1sRENHZVM0UHN5eERrVWNhMERsalExaXN5bXF0R2lHdTktOTFjSkI4ODJpNHNBekVVSm9nNVMydl…

Google News ue, 18 Aug 2026

TruBridge (TBRG) Reported Quarter: EPS Misses Its Estimate at the Close; Share Response: The Stock Closes Near Unchanged on the Day - Revenue Beat Analysis - dars.gov.et

<a href="https://news.google.com/rss/articles/CBMirAJBVV95cUxOTmw4bEZ0Z1h6aENXRVFaeW9PUGZOR2VPZm9uWFhROVV0RGdhcFFTOE5DeUktSXAwNndWLTU4Um5UUFVjZHZlZzA1dDVqYkxrdWVkeHVuaDlQdkRBaFg4YWJMdDZzQW9rOHhUY0hkN3dlV1cxTWtBSjFnb1FZRFJ0ZFZLQjlzVWN0WTFYOH…

TBRG — Frequently Asked Questions

What is the current share price of TBRG?

As of 2026-10-23 16:27 PDT, TBRG trades at $26.24 on NasdaqGM. Its 52-week range is $26.24 to $26.24.

What is the market capitalisation of TBRG?

TBRG has a market capitalisation of $393.58M on NasdaqGM.

What is the P/E ratio of TBRG?

TBRG trades at a trailing price-to-earnings (P/E) ratio of 90.48. The industry average P/E is 25.45. Its price-to-book (P/B) ratio is 2.16.

What is the return on equity (ROE) of TBRG?

TBRG has a return on equity (ROE) of 2.54%. Its return on capital employed (ROCE) is 4.70%.

Is TBRG a good stock to buy?

This page provides a data-driven analysis of TBRG, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

TBRG TBRG R2KPHARMA

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Analyst View

Latest News

TBRG Posts Q1 Earnings: How to Play the Stock Amid Pending Sell-off? - Yahoo Finance

TruBridge Inc. (NASDAQ: TBRG) Share Price, TBRG Stock News, TBRG Share Price & Updates - kalkine.ca

TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now? - Yahoo Finance

TruBridge Announced Transfer or Voluntary Withdrawal of Listing - TradingView

TruBridge Stockholders Approve IKS Merger at Special Meeting - Yahoo Finance

TruBridge (TBRG) Reported Quarter: EPS Misses Its Estimate at the Close; Share Response: The Stock Closes Near Unchanged on the Day - Revenue Beat Analysis - dars.gov.et

TBRG — Frequently Asked Questions

What is the current share price of TBRG?

What is the market capitalisation of TBRG?

What is the P/E ratio of TBRG?

What is the return on equity (ROE) of TBRG?

Is TBRG a good stock to buy?

Explore More